BUZZ-Molecular Templates dips after board approves liquidation plan

Reuters
2024-10-12

** Shares of drug developer Molecular Templates fall ~21% to $1.16 in extended trading

** Late on Friday, MTEM said its board approved plan of liquidation and wind up through dissolution

** Says co continues to pursue strategic alternatives and potential funding sources

** Company says does not currently expect that its stockholders will receive value for their shares of common stock in connection with a dissolution

** MTEM plans to wind down early studies for two of its experimental cancer drugs, MT-6402 and MT-8421

** Says board approved a workforce reduction of substantially all of the company's employees, other than key members of management

** Up to Friday's close, stock down ~61% YTD

(Reporting by Mariam Sunny in Bengaluru)

((Mariam.ESunny@thomsonreuters.com))

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10